Evidence map›Paper›PMID 25973801›Full record

ArticlePloS one2015

Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental leishmaniasis.

Milena Menegazzo Miranda, Carolina Panis, Allan Henrique Depieri Cataneo, Suelen Santos da Silva, Natalia Yoshie Kawakami, Luiz Gonzaga de França Lopes, Alexandre Tadachi Morey, Lucy Megumi Yamauchi, Célia Guadalupe Tardelli de Jesus Andrade, Rubens Cecchini and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Murine Susceptibility toFrontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Parasite Killing ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Milena Menegazzo MirandaDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Carolina PanisLaboratory of Inflammatory Mediators, State University of Western Paraná, Francisco Beltrão, Paraná, Brazil.
Allan Henrique Depieri CataneoDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Suelen Santos da SilvaDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Natalia Yoshie KawakamiDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Luiz Gonzaga de França LopesDepartment of Organic and Inorganic Chemistry, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Alexandre Tadachi MoreyDepartment of Microbiology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Lucy Megumi YamauchiDepartment of Microbiology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Célia Guadalupe Tardelli de Jesus AndradeLaboratory of Electron Microscopy and Microanalysis, Department of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Rubens CecchiniDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Jean Jerley Nogueira da SilvaDepartment of Chemistry, State University of Roraima, Boa Vista, Roraima, Brazil.
José Maurício SforcinDepartment of Microbiology and Immunology, Biosciences Institute, São Paulo State University, Botucatu, São Paulo, Brazil.
Ivete Conchon-CostaDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Wander Rogério PavanelliDepartment of Pathology Science, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Universidade Estadual de Londrina · BRUniversidade Estadual de Roraima · BRUniversidade Estadual do Paraná · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fact that drugs currently used in the treatment of Leishmania are highly toxic and associated with acquired resistance has promoted the search for new therapies for treating American tegumentary leishmaniasis (ATL). In this study, BALB/c mice were injected in the hind paw with Leishmania (Leishmania) amazonensis and subsequently treated with a combination of nitric oxide (NO) donor (cis-[Ru(bpy) 2imN(NO)](PF6)3) (Ru-NO), given by intraperitoneal injection, and oral Brazilian propolis for 30 days. Ru-NO reached the center of the lesion and increased the NO level in the injured hind paw without lesion exacerbation. Histological and immunological parameters of chronic inflammation showed that this combined treatment increased the efficacy of macrophages, determined by the decrease in the number of parasitized cells, leading to reduced expression of proinflammatory and tissue damage markers. In addition, these drugs in combination fostered wound healing, enhanced the number of fibroblasts, pro-healing cytokines and induced collagen synthesis at the lesion site. Overall, our findings suggest that the combination of the NO donor Ru-NO and Brazilian propolis alleviates experimental ATL lesions, highlighting a new therapeutic option that can be considered for further in vivo investigations as a candidate for the treatment of cutaneous leishmaniasis.

Indexed as

Administration, OralAnimalsCell MovementCollagenCytokinesDrug SynergismDrug Therapy, CombinationFemaleFibroblastsHindlimbInjections, IntraperitonealLeishmaniaLeishmaniasis, CutaneousMacrophagesMiceMice, Inbred BALB CCollagenCytokinesNitric OxideNitric Oxide DonorsPropolis

Identifiers

PMID25973801
PMCPMC4431861
OpenAlexW1867591976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.